THANK YOU SO MUCH FOR ALL THE SUBMISSIONS! 🤩🤩

We are truly touched to hear all the success stories from each and everyone of you. Your stories are truly inspiring and we are glad that you're sharing them in this community!

And good news! We have given out the points to all the winners of the Wellous Merdeka Day Campaign. For those who did not fulfil all the criteria, don't worry - there will be a consolation prize as well! Drop by your points history to find out more.

Once again, thank you for joining! And stay tuned for more campaigns in the future.

Just join! How to purchase the product? 😊

Knees pain feel better in 5 days!

Your Immune System Evolves—So Should Your Care! 💪✨

From babyhood to senior years, your immunity changes. Give it the right support at every stage for a healthier, stronger you!

Zenso helps alot with my weight management! #NationalDayWellous

Who says snacking is unhealthy?

Here we have 4 easy-to-prepare, delicious, healthy snacks choices for you to try this weekend!

Time to impress your loved ones (or just treat yourself good) with these tasty treats! 😀😎

New Start with Zenso😍
New weight goals to achieve healthier lifestyle!

How to make a purchase?

Level up your skin game with just ONE sachet! 🌟

LIVEON is here to change the rules – packed with the coolest, top-notch patented ingredients from around the globe for total skin rejuvenation. LIVEON - all the good stuff, no fuss! ✨

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Our latest newsletter dives deep into understanding liver health! You'll explore a range of common liver conditions, the ways to prevent viral hepatitis and fatty liver, and our featured products - LIVETAL & HOMEGA to support your liver health. Also, don't miss out on our Digital Detox Challenge to give your mind and body a break!🧡✨

Click the link below to access the full newsletter and learn more about keeping your liver healthy!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-en.pdf